What is the global market size of Duchenne Muscular Dystrophy Market?

Global Duchenne Muscular Dystrophy Market size was valued at USD 1301.44 million in 2021 and is poised to grow from USD 1362.61 million in 2022 to USD 2060.11 million by 2030, growing at a CAGR of 4.7% in the forecast period (2023-2030).

Global Duchenne Muscular Dystrophy Market Size, Share, Growth Analysis, By Therapy(Mutation Suppression, Exon Skipping Approach), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2024-2031

Report ID: SQSG35I2036 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 63 | Figures: 75

Global Duchenne Muscular Dystrophy Market News

In June 2022, Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series of bolt-on acquisitions by pharmaceutical companies looking to bolster their drug pipelines.
In Feb 2022, Recipharm acquires Portuguese CDMO as part of biologics expansion. CDMO GenIbet, specializes in producing biological clinical trial material and other viral vectors, for an undisclosed price.

Global Duchenne Muscular Dystrophy Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Duchenne Muscular Dystrophy Market size was valued at USD 1301.44 million in 2019 and is poised to grow from USD 1362.61 million in 2023 to USD 2060.11 million by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).

Global duchenne muscular dystrophy market is competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Pfizer Inc.', 'PTC Therapeutics Inc.', 'Sarepta Therapeutics', 'Santhera Pharmaceuticals', 'Solid Biosciences', 'Catabasis Pharmaceuticals', 'Summit Therapeutics', 'NS Pharma, Inc.', 'Wave Life Sciences', 'BioMarin Pharmaceutical Inc.', 'ReveraGen BioPharma Inc.', 'Bristol-Myers Squibb', 'Roche Holding AG', 'Daiichi Sankyo Company, Limited', 'Vertex Pharmaceuticals', 'Italfarmaco S.p.A.', 'Biogen', 'Ultragenyx Pharmaceutical Inc.', 'FibroGen', 'Marathon Pharmaceuticals, LLC'

Prevalence of duchenne muscular dystrophy is on the rise, and factors that are driving its market growth include increased awareness campaigns about the disorder, the development of mutation-specific therapies, the rise in product pipelines, the introduction of therapies like Exondys51 and Translarna, and the use of corticosteroid-based anti-inflammatory drugs.

The introduction of novel pharmaceuticals and treatments, disease-modifying treatments, significant backing from numerous firms for drug research, and support from patient advocacy groups on the regulatory approval process are the main factors driving the global market for duchenne muscular dystrophy.

North America dominated the global duchenne muscular dystrophy market. The market in North America is expected to expand as a result of a number of important factors, including the rising prevalence of muscular dystrophy in the region, FDA drug approval, strong healthcare infrastructure supported by supportive government regulations, and medical reimbursement in the region and due to anticipated product launches.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Duchenne Muscular Dystrophy Market Size, Share, Growth Analysis, By Therapy(Mutation Suppression, Exon Skipping Approach), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2024-2031

Global Duchenne Muscular Dystrophy Market News

Global Duchenne Muscular Dystrophy Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Duchenne Muscular Dystrophy Market?

Who are the key vendors in the Global Duchenne Muscular Dystrophy Market?

What is the key driver of Global Duchenne Muscular Dystrophy Market?

What is the key market trend for Global Duchenne Muscular Dystrophy Market?

Which region accounted for the largest share in Global Duchenne Muscular Dystrophy Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300